Smita Tukaram Kumbhar et al. 2022. Engineered atenolol-glycoconjugates to target H9c2 cardiomyocyte cell lines. ACTA INNOVATIONS. 43, (Jun. 2022), 36–43. DOI:https://doi.org/10.62441/actainnovations.v43i.284.